Zimmer Biomet Agrees To Deal In $209M Transfer Pricing Case
Medical device maker Zimmer Biomet reached an agreement to settle its challenge of a $209 million tax bill, which the Internal Revenue Service had calculated after reallocating income from the company's...To view the full article, register now.
Already a subscriber? Click here to view full article